Added to YB: 2026-07-23
Pitch date: 2026-07-20
VENUSREM.NS [neutral]
Venus Remedies Limited
+3.54%
current return
Author Info
Nine One Capital is an India-focused investment manager. We are value-conscious investors in Indian listed companies. Sign up for the newsletter.
Company Info
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology.
Market Cap
INR 23.9B
Pitch Price
INR 1.6K
Price Target
N/A
Dividend
0.56%
EV/EBITDA
13.76
P/E
20.57
EV/Sales
2.83
Sector
Pharmaceuticals
Category
growth
Venus Remedies Q1 FY27 Update
VENUSREM.NS (earnings): Q1 FY27 rev +36% YoY (30% 2yr CAGR) on export momentum, EBITDA ~3x, PAT ₹23cr consol. Q1 seasonally weakest but -31% seq dip better than prior yrs (-40%, -33%). TTM PAT grew 2.5x to ₹115cr since coverage; stock re-rated ₹450→₹1,800. Sees further multiple upside vs peers.
Read full article (2 min)